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1a,25-Dihydroxyvitamin D3 added to human keratino-
cytes increases di¡erentiation through an activation
of the transcription factor activator protein 1. We have
previously reported that the 1a,25-dihydroxyvitamin
D3-induced increase of activator protein 1 DNA bind-
ing activity is mediated by a protein kinase C-indepen-
dent mechanism. The purpose of this study was to
investigate further the mechanisms by which 1a,25-
dihydroxyvitamin D3 modulates activator protein 1
DNA binding activity in cultured normal human
keratinocytes. Western blotting experiments revealed
that 1a,25-dihydroxyvitamin D3 caused a rapid and
transient activation of the mitogen-activated protein
kinases, extracellular signal regulated kinase 1/2 and c-
Jun N-terminal kinase 1. 1a,25-Dihydroxyvitamin D3
also enhanced the expression of the activator protein 1
subunits, c-Fos, Fra1, and c-Jun as determined by north-
ern and western blotting. The 1a,25-dihydroxyvitamin
D3-induced activator protein 1 DNA binding activity
was completely blocked by the MEK inhibitor PD
98059 indicating that the MEK/extracellular signal regu-
lated kinase pathway is involved in the activation of ac-
tivator protein 1. Transfection experiments showed that
1a,25-dihydroxyvitamin D3 also increased the activator
protein 1-dependent transactivation, which was com-
pletely blocked by expression of a dominant negative
Ras, suggesting that the 1a,25-dihydroxyvitamin
D3-induced activator protein 1 activity involves Ras-
dependent signaling. Furthermore, preincubation of
the keratinocytes with the speci¢c phosphatidylinositol
3-kinase inhibitors, Wortmannin and LY294002, de-
monstrated that the 1a,25-dihydroxyvitamin D3-in-
duced activation of extracellular signal regulated kinase
1/2 and c-Jun N-terminal kinase 1 required phosphati-
dylinositol 3-kinase activity. Finally, preincubation of
keratinocytes with a polyclonal antibody against the
membrane receptor annexin II, blocked the 1a,25-dihy-
droxyvitamin D3-induced activation of extracellular
signal regulated kinase 1/2 and c-Jun N-terminal kinase
1. Taken together, our results indicate that 1a,25-dihy-
droxyvitamin D3, via binding to the membrane
receptor annexin II, induces activation of the phos-
phatidylinositol 3-kinase/Ras/MEK/extracellular signal
regulated kinase 1/2 and c-Jun N-terminal kinase 1 sig-
nal transduction pathway resulting in increased expres-
sion of c-Fos, Fra1, and c-Jun, and subsequently
increased activator protein 1 DNA binding activity and
gene transcription. Key words: activator protein 1/annexin
II/1a,25-dihydroxyvitamin D3/keratinocytes/mitogen-activated
protein kinase. J Invest Dermatol 120:561 ^570, 2003
T
he strati¢ed epidermis is characterized by the migra-
tion of keratinocytes from the proliferative basal
compartment to the upper, terminally di¡erentiated
corni¢ed layers of the skin. As the cells migrate from
the basal layer, the keratinocytes undergo a distinct
pattern of di¡erentiation that is essential for the function of the
skin. 1a,25-Dihydroxyvitamin D3 (1a,25(OH)2D3), the hormon-
ally active form of vitamin D, decreases proliferation and in-
creases terminal di¡erentiation of precon£uent cultured human
keratinocytes (Hosomi et al, 1983; Smith et al, 1986). The cellular
actions of 1a,25(OH)2D3 have primarily been attributed to its in-
tracellular receptor, the vitamin D receptor (VDR), which be-
longs to the superfamily of nuclear steroid/thyroid receptors
(Haussler, 1986). Like several of these receptors, VDR is known
to bind as a heterodimer with the retinoid X receptor (RXR)
to DNA sequences in the promoter region of vitamin D respon-
sive genes (Demay et al, 1990; Noda et al, 1990; Zierold et al, 1994).
Recent studies have indicated that 1a,25(OH)2D3 also rapidly
instigates several, apparently VDR independent processes by
a number of signal transduction pathways, including altered
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phosphoinositide metabolism (Sorensen and Baran, 1995), in-
creased concentration of intracellular calcium (Jones and Sharpe,
1994), altered calcium transport (Nemere et al, 1984), protein
kinase C (PKC) activation (Hana¢n et al, 1995; Slater et al, 1995;
Chen et al, 1999), and activation of mitogen-activated protein
kinase (MAPK) (Marcinkowska et al, 1997; Chen et al, 1999).
How 1a,25(OH)2D3 mediates these rapid actions is still not fully
elucidated. Recent results have shown that 1a,25(OH)2D3 can
bind to the annexin II membrane receptor (Baran et al, 2000a)
and it has been speculated that annexin II is the surface mem-
brane receptor mediating the rapid actions of 1a,25(OH)2D3
(Baran et al, 2000b).
The MAPK cascade is a signaling pathway intimately involved
in cellular proliferation, di¡erentiation, and apoptosis (Xia et al,
1995;Whitmarsh and Davis, 1996; Chang and Karin, 2001). It con-
sists of three distinct layers of protein kinases, including a MEK
kinase (MEKK), which activates a MAPK kinase (MEK), which
in turn activates a MAPK (Robinson and Cobb, 1997). Three dis-
tinct MAPK signal transduction pathways have been identi¢ed in
mammalian cells, leading to activation of the MAPK the extra-
cellular signal regulated kinases (ERK), the c-Jun N-terminal ki-
nases (JNK, also known as stress-activated protein kinases;
SAPK), and p38 (Davis, 1993, 1994; Waskiewicz and Cooper,
1995). Once activated the MAPK may translocate to the nucleus
where they phosphorylate and activate a number of target pro-
teins (Cano and Mahadevan, 1995; Hill and Treisman, 1995; Karin
and Hunter, 1995; Robinson and Cobb, 1997).
Activator protein 1 (AP-1) is a nuclear transcription factor,
known to play an important part in keratinocyte di¡erentiation
(DiSepio et al, 1995; Rutberg et al, 1996; Sark et al, 1998; Johansen
et al, 2000). AP-1 is formed as homodimers between Jun (c-Jun,
JunB, JunD) proteins or heterodimers between Fos (c-Fos, FosB,
Fra1, Fra2) and Jun proteins (Angel and Karin, 1991). Once acti-
vated, the AP-1 complex binds to the 12-O-tetradecanoylphor-
bol-13-acetate response element, which is found in the promoter
region of several genes, including genes involved in keratinocyte
di¡erentiation, such as keratin 1 (Lu et al, 1994), keratin 5 (Casa-
torres et al, 1994), transglutaminase 1 (Yamada et al, 1994), and in-
volucrin (Welter et al, 1995).
We have previously shown that 1a,25(OH)2D3 increases the
AP-1 DNA binding activity in cultured human keratinocytes
(Johansen et al, 2000). In contrast to calcium, this induction was
PKC independent (Johansen et al, 2000). The exact mechanism by
which 1a,25(OH)2D3 increases the AP-1DNA binding activity in
human keratinocytes, however, was not elucidated. Recent results
have shown that 1a,25(OH)2D3-induced AP-1 DNA binding ac-
tivity in a human colonic carcinoma cell line is mediated by the
MAP kinases, ERK and JNK (Chen et al, 1999). Furthermore, it
has been demonstrated that the calcium-induced di¡erentiation
of keratinocytes is mediated by a Ras-independent activation of
the Raf/MEK/ERK1pathway (Schmidt et al, 2000). It is therefore
possible that activation of the MEK/ERK or JNK pathway plays
an important part in keratinocyte di¡erentiation.
Phosphatidylinositol 3 kinase (PI3 kinase) is a lipid kinase
composed of an 85 kDa (p85) regulatory subunit and a 110 kDa
(p110) catalytic subunit. The PI3 kinase is known to play a part in
a wide variety of cellular processes, including organization of
the cytoskeleton, cell growth, transformation, and prevention
of apoptosis (Fry, 1994; Toker and Cantley, 1997). Also it has
been suggested that the PI3 kinase may play a part in the
1a,25(OH)2D3-induced monocyte di¡erentiation (Hmama et al,
1999), and that PI3 kinase activity is essential for all-trans-retinoic
acid-induced granulocytic di¡erentiation of HL-60 cells (Bertag-
nolo et al, 1999). The PI3 kinase is also required for an activation
of the Ras/c-Raf1/MEK/ERK signaling cascade induced by va-
nadyl sulfate in Chinese hamster ovary cells (Pandey et al, 1999).
In this study we addressed the question whether the
1a,25(OH)2D3-induced AP-1 DNA binding activity seen in cul-
tured human keratinocytes after 36 h of incubation was due to a
PI3 kinase dependent activation of the MEK/ERK cascade. We
found that addition of 1a,25(OH)2D3 to cultured normal human
keratinocytes resulted in a rapid but transient phosphorylation of
ERK1, ERK2, and JNK1, which was accompanied by increased
expression of both c-Fos, Fra1, and c-Jun as determined at the
mRNA and protein levels. In addition, 1a,25(OH)2D3 increased
the AP-1 transcriptional activities in a Ras-dependent manner.
The 1a,25(OH)2D3-induced activation of ERK1/2 and JNK1
was downregulated by inhibition of both the MEK and the PI3
kinase, demonstrating that the PI3 kinase/Ras/MEK/ERK1/2 and
JNK1 pathway is the principal pathway in the 1a,25(OH)2D3-in-
duced activation of AP-1 and in the resulting di¡erentiation.
Finally, we present evidence suggesting that 1a,25(OH)2D3 acti-
vates the MAPK signal transduction pathway through the surface
membrane receptor, annexin II.
MATERIALS ANDMETHODS
Materials Keratinocyte serum-free medium, keratinocyte basal medium,
and dominant negative Ras (Ras-N17) cloned into pcDNA3 and
pcDNA3-Ras-N17 were obtained from Invitrogen (Carlsbad, CA).
1a,25(OH)2D3 dissolved in 2-propanol was kindly provided by Leo
Pharmaceuticals Products (Ballerup, Denmark). Wortmannin, LY294002
and PD 98059 were purchased form Calbiochem (San Diego, CA). AP-1
Consensus Oligo (50 -CGCTTGATGAGTCAGCCGGAA-30), Gel Shift
Binding 5Bu¡er, T4 Polynucleotide Kinase and T4 Polynucleotide
Kinase 10Bu¡er were obtained from Promega (Madison, WI).
[g-32P]adenosine triphosphate, Enhanced Chemiluminescence Detection
System (ECL), microspin G-25 columns and Nick Spin Columns
Sephadex G-50 ¢ne DNA-grade were provided by Amersham/Pharmacia
Biotech (Uppsala, Sweden). Complete (a protease inhibitor cocktail) was
purchased from Boehringer Mannheim (Mannheim, Germany). Trypsin,
ethylenediamine tetraacetic acid (EDTA), Tris base, Tris^HCl,
dithiothreitol (DTT), and boric acid were obtained from Sigma (St Louis,
MO). Antibodies against ERK, p38a (no cross-reactivity with p38b,
whereas cross-reactivity with p38g and p38d has not been ruled out),
phospo-c-Jun, JNK, and protein kinase B were purchased from Cell
Signaling Technology (Beverly, MA) and antibodies against TFIIB, c-Fos,
c-Jun, JunB, JunD, Fra1, Fra2, FosB, and annexin II were purchased
from Santa Cruz Biotechnology (Santa Cruz, CA). Fractionated
rabbit immunoglobulins were from DAKO (Glostrup, Denmark). DNA
probes recognizing c-Fos, Fra1, c-Jun, and GAPDH were from Geneka
Biotechnology Inc. (Montreal, Canada). The reporter construct p(AP-1)3-
lucþ containing three tandem copies of the AP-1 site was from Stratagene
(La Jolla, CA), and the CMV-b-galactosidase expression vector used
for normalization was from Clontech (Palo Alto, CA). SeaKem Gold
agarose gel were obtained from BioWhittaker Molecular Applications
(Rockland, ME).
Cell cultures Normal adult human keratinocytes were obtained by
trypsinization of skin samples from patients undergoing plastic surgery as
previously described (Kragballe et al, 1985). First-passage keratinocytes were
grown in keratinocyte serum-free medium. Twenty-four hours before
stimulation the medium was changed to keratinocyte basal medium
(without growth factors) in which the cells were stimulated. Cells were
grown at 37 C and 5% CO2 in an incubator. At 50^60% con£uency, as
judged by light microscopy, 1a,25(OH)2D3 10
^7
M ¢nal concentration was
added. The 1a,25(OH)2D3 stock solution was diluted in 2-propanol and
the ¢nal 2-propanol concentration in medium was 0.025%. In separate
experiments speci¢c inhibitors were added 30 min before stimulation.
Transient transfection assays Normal human keratinocytes were
transiently transfected in 12 well plates using E¡ectene (Qiagen, Valencia,
CA). Cells were maintained in keratinocyte basal medium for 24 h prior to
transfection. Transfections were performed with 75 ng p(AP-1)3-luc
þ
(Stratagene) reporter construct together with 0, 0.008, 0.04, 0.2, or 1 ng
pcDNA3-Ras-N17. Two nanograms of CMV-b-galactosidase were used
for normalization and empty expression vector was added to ensure equal
promoter load. Six hours following transfection fresh medium was added
and cells were subsequently incubated for 36 h, 48 h, or 60 h in
keratinocyte basal medium containing either vehicle (2-propanol) or
1a,25(OH)2D3 10
^7
M. Luciferase and b-galactosidase activities in cell
lysates were determined by standard techniques. Luciferase activities were
normalized to b-galactosidase activities. All transfections were made in
triplicate and repeated three times.
Isolation of the nuclear fraction Nuclear extracts were prepared as
previously described (Rosette and Karin, 1995; Johansen et al, 2000).
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Brie£y, cells were released from the culture £ask by a rubber policeman
followed by dilution in a hypoton bu¡er (10 mM HEPES, 10 mM KCl, 0.2
mM EDTA, 0.1 mM ethyleneglycol-bis-(b-aminoethylether)-N,N,N0,N0-
tetraacetic acid, 1 mM DTT, pH 7.9). Then the suspension was passed
through a 27 gauge needle six times and centrifuged at 10,000 g for
1.5 min. Pellet was resuspended in a hyperton bu¡er (20 mM HEPES,
0.4 mM NaCl, 1 mM EDTA, and 1 mM DTT, pH 7.9) and rotated at 41C
for 30 min before being centrifuged at 10,000 g for 5 min. The
supernatant was considered the nuclear extract. Protein concentration was
determined as previously described by Bradford (1976) with bovine serum
albumin as standard.
Labeling of consensus oligonucleotides for AP-1 Four microliters
of AP-1 consensus oligonucleotide (1.75 pmol per ml), 2 ml of T4
polynucleotide kinase 10Bu¡er (700 mM Tris^HCl, 100 mM MgCl2, and
50 mM DTT), 4 ml of [g-32P]adenosine triphosphate (3000 Ci per mmol at
10 mCi per ml), 8 ml nuclease-free water, and 2 ml T4 polynucleotide kinase
were added to an Eppendorf tube and incubated for 10 min at 371C before
the reaction was stopped by the addition of 1 ml 0.5 M EDTA. Finally,
200 ml of TE-Bu¡er (10 mMTris^HCl, pH 8 and 1mM EDTA) was added.
Labeled and unlabeled oligonucleotides were separated on a Nick spin
column at 300 g for 5 min.
Electrophoretic mobility shift assay Binding reactions consisted of
3^5 mg of nuclear protein, preincubated for 10 min at room temperature
in the incubation bu¡er [5 mM MgCl2, 2.5 mM EDTA, 2.5 mM DTT, 250
mM NaCl, 50 mM Tris^HCl, pH 7.5, 20% glycerol, 0.25 mg per ml poly(dI-
dC)]. Then, 1 ml of 32P-labeled AP-1 probe was added and incubations were
carried out for additional 20 min.The binding complexes were resolved on
a 4% polyacrylamide gel in 0.5TBE bu¡er (22.5 mM Tris base, 4 mM
boric acid, and 1 mM EDTA). Supershifts were performed by the addition
of 2 mg of the corresponding commercially available antibodies speci¢c
for Fra1 and c-Jun to the binding reactions, 15 min after the addition of
the 32P-labeled probe. Incubation was then allowed to proceed for an
additional 30 min.
In control experiments a speci¢c competitor (unlabeled AP-1 oligo) or a
nonspeci¢c competitor (unlabeled SP-1 oligo), were added 10 min before
addition of labeled AP-1 oligo.
Western blotting Keratinocytes were washed twice with ice-cold
phosphate-bu¡ered saline, lyzed with cold lysis bu¡er [50 mM Tris^HCl,
pH 6.8, 10 mM DTT, 10 mM b-glycerophosphate, 10 mM NaF, 0.1 mM Na
orthovanadate, 10% glycerol, 2.5% sodium dodecyl sulfate (SDS), 25 mM
phenylmethylsulfonyl £uoride and 50 complete (Boehringer Mann-
heim)], scraped from the plate and boiled for 3 min. Then the lysate was
centrifuged at 13,000 g for 3 min and the supernatant was collected and
assayed for protein concentration as described by Bradford (1976). Equal
protein amounts were separated by SDS^polyacrylamide gel electro-
phoresis (SDS^PAGE) and blotted on to nitrocellulose membranes.
Membranes were incubated with the appropriate primary antibody and
detected with either anti-rabbit IgG-horseradish peroxidase (Santa Cruz)
or anti-rabbit IgG-horseradish peroxidase (DAKO) in a standard ECL
reaction (Amersham) according to the manufacturers’ instructions.
RNA puri¢cation Cultured human keratinocytes were washed twice
with ice cold phosphate-bu¡ered saline, before 1 ml of TRIZOL reagent
was added for the isolation of total RNA as recommended by the
manufacturer (Gibco BRL/Life Technologies).
Northern blotting Total RNA (10 mg) was separated on a 1.25%
SeaKem Gold agarose gel and transferred to Hybond N membranes by
capillary blotting. The integrity of RNA was assessed by methylene blue
staining of the membrane. [g-32P]adenosine triphosphate-labeled probes
were generated using human c-Fos, Fra1, c-Jun, and GAPDH fragments
according to the manufacturer’s protocol (Geneka Biotechnology Inc.).
The probes were puri¢ed using microspin G-25 columns. Hybridization
with the 32P-labeled probes was carried out as recommended by the
manufacturer.
Statistics Results were expressed as mean7SD. For statistical analysis a
one-way ANOVA was done followed by a Student^Newman^Keuls test. To
test for normal distribution, a probability test was made. A probability of
po0.05 was regarded as statistically signi¢cant.
RESULTS
1a25ðOHÞ2D3 induces a rapid and transient activation of
the MAPK ERK1, ERK2, and JNK1 in cultured human
keratinocytes We have previously shown that 1a,25(OH)2D3
increases the AP-1 DNA binding activity in human
keratinocytes in a concentration-dependent manner (Johansen
et al, 2000). Furthermore, MAPK signaling pathways, including
both ERK and JNK, have been known to in£uence AP-1
transcriptional activity by increasing both the expression of AP-
1 proteins and altering their phosphorylation (Whitmarsh and
Davis, 1996). Therefore, studies were performed to assess the
e¡ect of 1a,25(OH)2D3 on the MAPK. After incubation of
cultured human keratinocytes with 1a,25(OH)2D3 10
^7
M or
vehicle (2-propanol) for the indicated time periods (Fig 1),
activated ERK, JNK, and p38 were determined in whole cell
lysates by western blotting using speci¢c antibodies recognizing
speci¢cally the dually phosphorylated active forms of ERK1/2,
JNK1/2, and p38. Within 2 min 1a,25(OH)2D3 induced a rapid
activation of both ERK1 and ERK2, which returned to the
basal level within 1 h (Fig 1a). Equal protein loading, was
determined by assessing the total amount of ERK1 and ERK2.
Only the phosphorylated forms of ERK1 and ERK2 were
increased after incubation with 1a,25(OH)2D3 (Fig 1a). JNK1,
but not JNK2, was also rapidly activated by 1a,25(OH)2D3. As
seen in Fig 1(b) the phosphorylated form of JNK1 was
detectable 2 and 5 min after the addition of 1a,25(OH)2D3,
whereas the phosphorylated form of JNK2 was undetectable at
any time points. Total JNK1 and JNK2 expression were similar
at all time points investigated (Fig 1b). In control experiments
keratinocytes were exposed to ultraviolet (UV)B irradiation,
Figure1. Time course study of the e¡ects of 1a,25(OH)2D3 on the
expression and activation of ERK1/2, JNK1/2, and p38 in cultured
human keratinocytes. Keratinocytes were treated with 1a,25(OH)2D3
10^7 M or vehicle for the indicated time periods.Whole cell extracts (50 mg
of protein) were separated by SDS^PAGE on a 8^16% gradient gel and
blotted on to a nitrocellulose membrane. After blotting, speci¢c antibodies
were used to detect both phosphorylated and total ERK1/2 (a), JNK1/2 (b),
and p38 (c).Whole cell extracts from human keratinocytes irradiated with
UVB for 1min served as a positive control for phosphorylated JNK1/2 and
p38. Representative results of at least three separate experiments are shown.
MAP-KINASE DEPENDENTACTIVATION OFAP-1 BY 1A,25(OH)2D3 563VOL. 120, NO. 4 APRIL 2003
which potently increased the levels of the phosphorylated form
of both JNK1 and JNK2 (Fig 1b). No signi¢cant changes of the
phosphorylated form of p38, as determined by densitometry,
was seen after incubation with 1a,25(OH)2D3 (Fig 1c). Again
UVB irradiation was used as a positive control to induce
phosphorylation of p38.
1a; 25ðOHÞ2D3 induced phosphorylation of c-Jun To
determine whether the 1a,25(OH)2D3-induced phosphorylation
of the ERK and JNK1 led to phosphorylation of the c-Jun
protein, western blotting was performed using a speci¢c
antibody recognizing only the phosphorylated form of c-Jun.
When cultured human keratinocytes were incubated with
1a,25(OH)2D3 10
^7
M, phosphorylation of c-Jun was seen as
early as 2 min after the incubation was started (Fig 2). The
phosphorylation of c-Jun was transient and lasted for 20 min
(Fig 2). Only the level of the phosphorylated form of c-Jun was
increased, whereas there was no regulation of total c-Jun at this
early time point (Fig 2).
1a; 25ðOHÞ2D3 increases the expression of c-Fos, Fra1, and
c-Jun in human keratinocytes We then determined whether
the incubation with 1a,25(OH)2D3 resulted in any changes in
the expression of the various Jun and Fos proteins. Whole cell
extracts were prepared from cultured human keratinocytes
incubated with 1a,25(OH)2D3 or vehicle (2-propanol). c-Fos (62
kDa) expression was signi¢cantly increased by 1a,25(OH)2D3.
This increase was seen after 6 h and it reached a maximum after
24 h (2.6-fold, po0.01) (Fig 3a). Also, the 43 kDa Fra1 protein
was detected in the keratinocytes. The amount of Fra1 increased
signi¢cantly after 12 h (1.8-fold, po0.05) of incubation with
1a,25(OH)2D3, and reached a maximum after 36 h (3.2-fold,
po0.01) (Fig 3a). After 72 h the amount of Fra1, in both vehicle
and 1a,25(OH)2D3 stimulated cells, was barely detectable. Fra2
(38 kDa) was also detected in human keratinocytes, but the
expression was not changed by 1a,25(OH)2D3 (Fig 3a). FosB
was not detected in whole cell extracts from keratinocytes
incubated with or without 1a,25(OH)2D3 (data not shown).
The expression of the 39 kDa c-Jun protein was also increased
by 1a,25(OH)2D3 (Fig 3b). The level of c-Jun reached a
maximum after 24 h (2.4 -fold, po0.01) and had almost returned
to the control level after 72 h (Fig 3b). In contrast no signi¢cant
changes in the expression of JunB (43 kDa) and JunD (39 kDa)
were seen (Fig 3b). This conclusion was corroborated by
densitometric analysis (numerical data not shown).
To determine whether the 1a,25(OH)2D3-induced expression
of c-Fos, Fra1, and c-Jun was MEK dependent, the keratinocytes
were preincubated for 30 min with a speci¢c MEK inhibitor, PD
98059 (50 mM) (Alessi et al, 1995) before the addition of
1a,25(OH)2D3 for 24^48 h. Western blotting demonstrated that
PD 98059 completely blocked the 1a,25(OH)2D3-induced
increase in both c-Fos, Fra1, and c-Jun expression (Fig 3c).
Figure 2. Time course study of the 1a,25(OH)2D3-induced phos-
phorylation of c-Jun in human keratinocytes. Whole cell extracts
(50 mg of protein) from human keratinocytes treated with 1a,25(OH)2D3
10^7 M or vehicle were isolated and separated by SDS^PAGE on a 8^16%
gradient gel. After blotting the separated proteins were probed with a speci-
¢c antibody recognizing only c-Jun phosphorylated on serine 63. Equal
loading was con¢rmed by incubation with an antibody recognizing total c-
Jun protein. Representative results of four separate experiments are shown.
Figure 3. Western blot analysis of the various AP-1 proteins in hu-
man keratinocytes.Whole cell extracts (50 mg of protein) from human
keratinocytes treated with 1a,25(OH)2D3 10
^7
M for the indicated time per-
iods were isolated and separated by SDS^PAGE on a 8^16% gradient gel.
After electroblotting, the separated proteins were probed with anti-c-Fos,
anti-Fra1, or anti-Fra2 (a) or anti-c-Jun, anti-JunD, or anti-JunB antibodies
(b). (c) Human keratinocytes were pretreated with or without PD 98059
before stimulation with 1a,25(OH)2D3 10
^7
M for 24^48 h. Equal loading
was con¢rmed by incubation with an anti-TFIIB antibody. Representative
results of four separate experiments are shown.
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Incubation with PD 98059 (50 mM) alone did not cause any
regulation in the expression of the Jun and Fos proteins (data
not shown).
In all experiments the membranes were stripped by boiling for
10 min, before incubation with a speci¢c antibody recognizing
TFIIB. This was used as a control for equal protein load.
c-Fos, Fra1, and c-Jun mRNA levels Northern blotting was
performed to investigate whether the increased expression of the
AP-1 subunits c-Fos, Fra1, and c-Jun was paralleled by an
increased accumulation of the corresponding mRNA. Total
RNA was isolated from human keratinocytes incubated with
1a,25(OH)2D3 10
^7
M or vehicle (2-propanol) for the indicated
time periods (Fig 4). A signi¢cant increase in the expression of
c-Fos (1.8-fold, po0.01), 3.3 kb Fra1 (3.8-fold, po0.01), 1.7 kb
Fra1 (5.2-fold, po0.01), and c-Jun (3-fold, po0.01) mRNA
were seen after the addition of 1a,25(OH)2D3. The levels of
these mRNA were increased after 1 h and continued to in-
crease during the following 2^12 h (Fig 4). In all experiments
the membranes were stripped by boiling for 10 min, before
hybridization with a GAPDH speci¢c probe to demonstrate
equal RNA load.
MEK-dependent ERK1/2 and JNK1 activation Western
blotting analysis showed that 1a,25(OH)2D3-induced phos-
phorylation of ERK1 and ERK2 was completely blocked when
keratinocytes were preincubated with PD 98059 (50 mM) for 30
min before stimulation with 1a,25(OH)2D3 10
^7
M (Fig 5a). No
regulation on total ERK1 and 2 expressions was seen. Also the
1a,25(OH)2D3-induced JNK1 activation was blocked by MEK
inhibition, whereas total JNK1 and 2 expression was unchanged
(Fig 5b). UVB irradiation was included as a positive control.
Incubation with PD 98059 (50 mM) alone did not result in any
phosphorylation of ERK and JNK (data not shown). Taken
together, these results indicate that 1a,25(OH)2D3-induced
activation of ERK1/2 and JNK1 requires MEK activation.
MEK-dependent activation of AP-1 We have previously
shown that the 1a,25(OH)2D3-induced AP-1 DNA binding
activity was PKC independent (Johansen et al, 2000). In order to
determine whether this activation was MEK dependent, AP-1
DNA binding activity was determined by electrophoretic
mobility shift assays of nuclear extract from keratinocytes
pretreated with 50 mM of PD 98059 for 30 min, before
stimulation with 1a,25(OH)2D3 10
^7
M. As shown in Fig 6(a)
and 1a,25(OH)2D3 signi¢cantly increased the AP-1 DNA
binding activity after 48 h, with a maximal increase of
approximately 130% compared with vehicle-treated cells.
Interestingly, when keratinocytes were preincubated with PD
98059 the 1a,25(OH)2D3-induced increase in AP-1 DNA
binding activity was completely blocked (Fig 6a), demonstra-
ting that MEK activity is an essential step in the 1a,25(OH)2D3-
induced signal transduction pathway resulting in increased AP-1
DNA binding activity in cultured human keratinocytes.
Incubating the keratinocytes with PD 98059 alone did not a¡ect
the AP-1 DNA binding activity (data not shown).
In control experiments, preincubation with an unlabeled AP-1
oligo completely abolished binding of the 32P-labeled AP-1 oligo,
whereas addition of a control oligo, SP-1, did not a¡ect the
binding of the 32P-labeled AP-1 oligo, indicating that the AP-1
DNA binding activity was speci¢c for the AP-1 target sequence
(Fig 6b). Furthermore, the addition of c-Jun or Fra1 antibodies
resulted in a supershifted band (Fig 6b) demonstrating the
presence of these two proteins in the detected AP-1 DNA
binding complex.
PI3 kinase-dependent activation of ERK1/2 and JNK1 To
determine whether the PI3 kinase plays a part in 1a,25(OH)2D3-
induced phosphorylation of ERK1/2 and JNK1, keratinocytes
were preincubated with the PI3 kinase inhibitor Wortmannin
(Powis et al, 1994) for 30 min before the addition of
1a,25(OH)2D3. Wortmannin 100 nM completely abolished the
1a,25(OH)2D3-induced phosphorylation of ERK1/2 (Fig 7a)
and JNK1 (Fig 7b). No regulation on total ERK1/2 and JNK1/2
Figure 3. Continued
Figure 4. c-Fos, Fra1, and c-Jun mRNA expression in human kera-
tinocytes after incubation with 1a,25(OH)2D3.Total RNA 10 mg from
human keratinocytes incubated with 1a,25(OH)2D3 10
^7
M for the indi-
cated time periods, were isolated and northern blotting was carried out.
Total RNA was hybridized with c-Fos, Fra1, and c-Jun speci¢c probes.
Equal loading of the RNAwas veri¢ed by GAPDH. The gels shown are
one representative of four separate experiments.
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expression was seen. Similar results were obtained with another
PI3 kinase inhibitor, LY294002 (10 mM) (Vlahos et al, 1994) (data
not shown).Wortmannin (100 nM) or LY294002 (10 mM) added to
the keratinocytes alone did not result in any phosphorylation of
ERK and JNK (data not shown).
1a; 25ðOHÞ2D3 increases AP-1-mediated transactivation in
human keratinocytes by a Ras-dependent mechanism To
assess the potential ability of 1a,25(OH)2D3 to induce AP-
1-mediated gene transcription, human keratinocytes were
transfected with an AP-1 responsive reporter construct,
containing three AP-1 binding sites upstream of a luciferase
reporter gene, p(AP-1)3 -luc
þ . After transfection the
keratinocytes were incubated with 1a,25(OH)2D3 or vehicle
(2-propanol). 1a,25(OH)2D3, increased the luciferase activity
signi¢cantly (po0.05) at 36 h, 48 h, and 60 h, where the
1a,25(OH)2D3-treated cells exhibited a 65% increase in the
normalized luciferase activity compared with cells receiving
vehicle (Fig 8). To evaluate the role of Ras in AP-1 activation by
1a,25(OH)2D3, keratinocytes were cotransfected with p(AP-1)3 -
lucþ and a dominant negative Ras expression plasmid (Ras-
N17). First the dose^response of transfected Ras-N17 was
established and used to de¢ne a window in which no signi¢cant
e¡ects on expression of the normalizing vector or cell
morphology were observed. Surprisingly, we found that the
amount of cotransfected Ras-N17 should be kept below 1 ng per
well of a 12-well plate. Using this window we next showed that
cotransfected Ras-N17 inhibited AP-1-mediated transactivation
in a concentration-dependent manner (Fig 8). This indicates
that the 1a,25(OH)2D3-induced AP-1 transactivating activity is
dependent on Ras activation.
1a; 25ðOHÞ2D3-induced ERK1/2 and JNK1 activation is
inhibited by preincubation with an antibody against
annexin II Annexin II has been suggested to act as a surface
membrane receptor for 1a,25(OH)2D3 (Baran et al, 2000b). To
determine whether the 1a,25(OH)2D3-induced ERK and JNK
activation is mediated through annexin II, human keratinocytes
were pretreated with or without a rabbit polyclonal antibody to
Figure 5. MEK-dependent activation of ERK1/2 and JNK1 in hu-
man keratinocytes. Keratinocytes were preincubated with or without
PD 98059 for 30 min before incubated with 1a,25(OH)2D3 10
^7
M for the
indicated time periods.Whole cell extracts (50 mg of protein) were sepa-
rated on a 8^16% gradient gel before being electroblotted on to a nitrocel-
lulose membrane. Active ERK1/2 and JNK1/2 were detected by anti-
phospho-ERK1/2 antibodies (a) and anti-phospho-JNK1/2 antibodies (b),
respectively.Whole cell extracts from human keratinocytes irradiated with
UVB for 1 min served as a positive control for phosphorylated JNK1/2.
Representative results of four separate experiments are shown.
Figure 6. 1a,25(OH)2D3 induced AP-1 DNA binding activity is sen-
sitive to MEK inhibition. Human keratinocytes were incubated with
1a,25(OH)2D3 10
^7
M for 48 h before AP-1 DNA binding activity was as-
sayed by electrophoretic mobility shift assay. In separate experiments kera-
tinocytes were pretreated with PD 98059 (50 mM) for 30 min and then
incubated with 1a,25(OH)2D3 for 48 h before AP-1 DNA binding activity
was determined. npo0.05 compared with keratinocytes cultured without
1a,25(OH)2D3.
nnpo0.05 compared with keratinocytes cultured with
1a,25(OH)2D3 and without PD 98059. Each bar represents the mean7SD
from ¢ve separate experiments (a). Keratinocyte nuclear extracts were incu-
bated with the indicated amounts of the indicated nonlabeled competitor
oligonucleotides or with anti-c-Jun or anti-Fra1 antibodies for 10 min prior
to the addition of a 32P-labeled AP-1 binding sequence (b).
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annexin II for 30 min before incubation with 1a,25(OH)2D3 10
^7
M for 2^10 min. In control experiments, human keratinocytes
were pretreated with fractionated rabbit immunoglobulins,
prepared from sera of nonimmunized rabbits, for 30 min before
incubation with 1a,25(OH)2D3 10
^7
M for 2^10 min.Whole cell
extracts (50 mg of protein) were isolated and western blotting
was performed. Preincubation with an antibody against annexin II
completely abolished the 1a,25(OH)2D3-induced phosphorylation
of ERK1/2 and JNK1 (Fig 9), whereas no changes were seen
in control experiments with rabbit immunoglobulins from
nonimmunized rabbits. Furthermore, treatment of the cells with
the annexin II antibody alone did not a¡ect the phosphorylation
of ERK and JNK (data not shown). These results suggest that
annexin II may serve as a surface membrane receptor for
1a,25(OH)2D3 causing activation of the signal transduction
pathway leading to phosphorylation of ERK1/2 and JNK1.
DISCUSSION
In this study we have shown that 1a,25(OH)2D3 induces activa-
tion of the PI3 kinase/Ras/MEK/MAPK (ERK1/2 and JNK1)
signaling pathway in cultured human keratinocytes resulting in
increased expression of c-Fos, Fra1, and c-Jun and subsequently
increased AP-1DNA binding and AP-1-mediated transactivation.
We furthermore suggest that this signal transduction cascade is
activated by 1a,25(OH)2D3 through binding to the membrane re-
ceptor annexin II.
1a,25(OH)2D3 has previously been shown to induce keratino-
cyte di¡erentiation (Hosomi et al, 1983; Smith et al, 1986), and we
(Johansen et al, 2000) and others (Rutberg et al, 1996; Bikle et al,
2001) have shown that di¡erentiation involves activation of AP-1.
Increased AP-1 DNA binding activity was seen after 24^48 h of
incubation with 1a,25(OH)2D3 (Johansen et al, 2000), demonstrat-
ing that the e¡ect of 1a,25(OH)2D3 was not due to an immediate
e¡ect on AP-1. In this study we show that 1a,25(OH)2D3 in-
creases AP-1 DNA binding activity by inducing synthesis of spe-
ci¢c Jun and Fos proteins that then form the AP-1 dimers. In
accordance with the delayed e¡ect on AP-1 DNA binding activ-
ity, increased expression of speci¢c Jun and Fos proteins was seen
from 6 to 72 h after 1a,25(OH)2D3 was added.
In accordance with the results obtained in this study ERK1/2
activation has previously been demonstrated in human keratino-
cytes stimulated with 1a,25(OH)2D3 (Gniadecki, 1996). In other
cell types, activation of ERK has been shown to increase the
expression of members of the Fos protein family (Whitmarsh
and Davis, 1996). In this study we showed that activation of
Figure 7. PI3 kinase dependent activation of ERK1, ERK2, and
JNK1. Human keratinocytes were preincubated with 10 nM Wortmannin
(WT) for 30 min before incubation with 1a,25(OH)2D3 10
^7
M for the in-
dicated time periods.Whole cell extracts (50 mg of protein) were isolated
and separated by SDS^PAGE on a 8^16% gradient gel. Activated ERK1/2
and JNK1/2 were detected by anti-phospho-ERK1/2 antibodies (a) and
anti-phospho-JNK1/2 antibodies (b), respectively.Whole cell extracts from
keratinocytes treated with UVB irradiation served as a positive control for
phosphorylated JNK1/2. Data shown are one representative of four separate
experiments.
Figure 8. Dominant negative Ras represses 1a,25(OH)2D3-induced
AP-1 transactivating activity in normal human keratinocytes.
Normal human keratinocytes were transiently transfected with 75 ng
p(AP-1)3 -luc
þ reporter construct and increasing amounts of the
pcDNA3-Ras-N17 encoding the dominant negative Ras-N17 mutant pro-
tein (0.008 ng, 0.04 ng, 0.2 ng, or 1 ng). Cells were subsequently treated
with medium containing either vehicle (2-propanol) or 10^7 M
1a,25(OH)2D3 for 36 h, 48 h, or 60 h prior to harvest. In all transfections
empty expression vector was added to ensure equal promoter load, and
CMV-b-galactosidase was used for normalization. Reporter activity was
normalized to b-galactosidase values, and fold induction is presented as
the mean7SD. npo0.05 compared with p(AP-1)3-lucþ -transfected cells
treated with vehicle.
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ERK1/2 and JNK1 by 1a,25(OH)2D3 led to an increased c-Fos,
Fra1, and c-Jun expression at both the mRNA and protein levels.
Expression of other Jun and Fos family members was not altered
by 1a,25(OH)2D3. The Fos and Jun members that have been
shown to be expressed (c-Fos, Fra1, Fra2, c-Jun, JunB, and JunD)
all participate in AP-1 formation as previously shown by super-
shift (Johansen et al, 2000). Furthermore, this study showed no
changes in the composition of untreated vs 1a,25(OH)2D3-treated
keratinocytes. Chen et al (1999) have shown that 1a,25(OH)2D3
increases the protein level of c-Jun in Caco-2 cells, whereas they
did not ¢nd any regulation of c-Fos and Fra1 expression. The dif-
ferent cell types investigated may explain these di¡erences.
Recent results have shown that in general c-Jun and JunD act
as positive regulators, whereas JunB acts as a suppressor of the ex-
pression of epidermal-speci¢c genes (DiSepio et al, 1995), indicat-
ing that various AP-1 homodimers or heterodimers carry out
cell-speci¢c regulation of speci¢c genes. It is therefore note-
worthy that incubation of cultured human keratinocytes with
1a,25(OH)2D3 resulted in an increased expression of only c-Jun,
c-Fos, and Fra1 demonstrating that 1a,25(OH)2D3 activates ex-
pression of speci¢c AP-1 subtypes, which in turn may result in
selective activation of AP-1 responsive genes in a manner depen-
dent on the composition of the AP-1 dimers and promoter
context.
The MAPK signaling pathways, including both ERK and
JNK, in£uence AP-1 transcriptional activity by increasing speci¢c
Jun and Fos proteins and by altering the phosphorylation of AP-1
subunits (Whitmarsh and Davis, 1996). In this study we show that
addition of 1a,25(OH)2D3 did not lead to activation of p38
MAPK indicating that p38 MAPK is not involved in
1a,25(OH)2D3-induced keratinocyte di¡erentiation. This is simi-
lar to 1a,25(OH)2D3-induced monocytic di¡erentiation of HL-
60 cells, which was enhanced by inhibition of the p38 MAPK
due to an upregulation of JNK and AP-1 (Wang and Studzinski,
2001).
We have previously demonstrated that 1a,25(OH)2D3-induced
di¡erentiation of human keratinocytes is mediated via a PKC-in-
dependent upregulation of the AP-1 DNA binding activity,
whereas calcium-induced keratinocyte di¡erentiation is PKC
dependent (Johansen et al, 2000). Moreover, it was recently
shown that the calcium-induced di¡erentiation of human kerati-
nocytes is mediated by a Ras-independent activation of the Raf/
MEK/ERK signaling pathway (Schmidt et al, 2000), whereas this
study showed that the 1a,25(OH)2D3-induced increase in AP-1
transactivating activity in human keratinocytes was Ras depen-
dent. These data strongly indicate that the signal transduction
pathways leading to AP-1 activation and subsequently di¡erentia-
tion of human keratinocytes is di¡erent for calcium and
1a,25(OH)2D3.
PI3 kinase is another kinase that has been shown to play a part
in the activation of the MAPK signaling pathway (Baier et al,
1999; Pandey et al, 1999). Retinoic acid induces the expression of
PI3 kinase g resulting in increased ERK2 activation in the mye-
lomonocytic cell-line U937 (Baier et al, 1999). Furthermore, it has
been shown that PI3 kinase activity is essential for the all-trans-
retinoid acid-induced di¡erentiation of HL-60 cells (Bertagnolo
et al, 1999), and that the PI3 kinase is involved in the
1a,25(OH)2D3-induced di¡erentiation of both myeloid cells and
HL-60 cells (Marcinkowska et al, 1998; Hmama et al, 1999). Simi-
larly, we found that the speci¢c PI3 kinase inhibitors,Wortman-
nin and LY294002 (Powis et al, 1994; Vlahos et al, 1994), both
completely blocked the 1a,25(OH)2D3-induced phosphorylation
of ERK1/2 and JNK1 in human keratinocytes, indicating that
ERK1/2 and JNK1 are activated by 1a,25(OH)2D3 through a PI3
kinase-dependent mechanism. Several downstream e¡ectors of
activated PI3 kinase have been identi¢ed, including the Akt/pro-
tein kinase B (Vanhaesebroeck and Alessi, 2000); however, sur-
prisingly we found no activation of protein kinase B in cultured
human keratinocytes incubated with 1a,25(OH)2D3 (data not
shown).
Figure 9. E¡ect of anti-annexin II antibody on the 1a,25(OH)2D3-
induced ERK1/2 and JNK1 phosphorylation. Human keratinocytes
were incubated either with 1a,25(OH)2D3 10
^7
M or pretreated with an an-
nexin II polyclonal antibody (0.2 mg per ml) for 30 min before incubated
with 1a,25(OH)2D3 10
^7
M for the indicated time periods.Whole cell ex-
tracts (50 mg of protein) were isolated and separated on a 8^16% SDS gel.
After blotting speci¢c antibodies were used to detect both phosphorylated
and total ERK1/2 (a) and JNK1/2 (b). Whole cell extracts from keratino-
cytes treated with UV irradiation served as a positive control for phos-
phorylated JNK1/2. Results shown are one representative of four separate
experiments.
Figure10. Schematic scenario of AP-1 activation induced by
1a,25(OH)2D3 in human keratinocytes.
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Annexin II has previously been demonstrated immunohisto-
chemically in the epidermal layer in neonatal foreskin (Ma and
Ozers, 1996). Later it has been suggested that annexin II may serve
as a surface membrane receptor for the rapid actions of
1a,25(OH)2D3 (Baran et al, 2000b). In this study preincubation
of cultured keratinocytes with a polyclonal antibody directed
against annexin II reduced the 1a,25(OH)2D3-induced phos-
phorylation of ERK1/2 and JNK1. Our data, therefore, support
the idea that the 1a,25(OH)2D3-induced activation of the MAPK
signal transduction pathway is mediated by the annexin II mem-
brane receptor. Annexin II may be the membrane receptor acti-
vating the signal transduction pathway by which 1a,25(OH)2D3
induces keratinocyte di¡erentiation. By immunohistochemical
staining Ma and Ozers (1996) determined that annexin II is loca-
lized as a band at the cell periphery in all nucleated epidermal
cells, suggesting that annexin II is present close to the cell mem-
brane in undi¡erentiated keratinocytes.
Con£icting data exist on whether PI3 kinase is upstream of Ras
or vice versa, depending on the cell type and the circumstances
studied (Pandey et al, 1999; Wennstrom and Downward, 1999;
Dajee et al, 2002). This hierarchy has not been investigated in this
study. Based on our results, however, we propose a model of the
signal transduction pathway induced by 1a,25(OH)2D3 (Fig 10).
In this model, 1a,25(OH)2D3 binds to the membrane receptor an-
nexin II, which leads to a PI3 kinase and/or Ras-dependent acti-
vation of the MEK/MAPK pathway. ERK1/2 and JNK1 are
rapidly activated by phosphorylation leading to increased synthesis
of the c-Fos, Fra1, and c-Jun proteins in conjunction with en-
hanced AP-1 DNA binding activity and increased transcription
of speci¢c genes involved in cell di¡erentiation.
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